Clinical and statistical aspects of gastrointestinal bleeding course in patients with cardiovascular system pathology.
DOI:
https://doi.org/10.26641/2307-0404.2019.1.162176Keywords:
gastrointestinal bleeding, pathology of the cardiovascular system, ForrestAbstract
We have collected, processed and analyzed the results of treatment of 329 patients with gastrointestinal bleedings in which the course of the underlying disease is aggravated by the pathology of the cardiovascular system, in Communal institution "Dnipro Clinical Emergency Care Association" of Dnipro City Council» in the period for 2017. First, the frequency of background diseases was determined, chronic pathology being 93.4%. Ischemic heart disease (IHD): cardiosclerosis of various origins (post-infarction, diffuse, atherosclerotic), hypertonic disease (HD) - HD-I, HD-II, HD-III are the most common, while acute disorders of cerebral circulation, the state after coronary artery bypass surgery, renal artery bypass, arrhythmias, acute myocardial infarction made up 16 (5%), 1 (0.3%), 3 (1%), 1 (0.3%), respectively. Secondly, the quality of endoscopic hemostasis in case of ulcerative bleeding from the stomach, duodenum, gastroenteroanastomosis, was assessed by Forrest classification, connecting the results with the accompanying pathology of the cardiovascular system. We found that active bleeding F I was determined in 24 people (7.3%), of which F Ia – in 14 (4.3%), F Ib – in 10 (3%). Unstable hemostasis with a high risk of recurrent F II bleeding, was observed in 251 patients, which makes up 76.2%, and F III – in 54 (16.5%). The degree of blood loss was directly influenced by drug – anticoagulants, antiplatelet agents, hypotensive drugs, as well as their combinations, aimed at correcting the rheological properties of blood. Depending on the degree of blood loss, the quality of hemostasis, the general condition of the patient, the treatment tactics for this cohort of patients was determined. 313 patients received conservative treatment, which made up 95.1%. 16 patients were operated. Postoperative mortality is 12,5%. The overall mortality of the above cohort is 10%.References
Bereznytskyi YS, Mishalov VH, Zakharash MP. Surgery: textbook for students of higher medical educational institutions. Nova Knyha. 2016:712. Ukrainian.
Verbitsky VG, Bagnenko SF, Kurygin AA. [Gastrointestinal bleedings of ulcer etiology: Pathogenesis, diagnosis, treatment]. Moskva, Politekhnika. 2004;242. Russian.
Glazova AV, Poteshkina NG. [Gastroprotection in patients receiving non-steroidal anti-inflammatory drugs and antithrombotic therapy]. Rossiyskiy meditsinskiy Journal. 2012;1:46-50. Russian.
Gostishchev VK, Yevseyev MA. [Gastroduodenal bleeding of ulcerative etiology]. GEOTAR-Media. 2016;384. Russian.
Grigoryan RA. [Abdominal surgery: in 2 volumes]. OOO «Meditsinskoe informatsionnoe agenstvo». 2006;1:226-66. Russian.
Rozanov BS. [Gastric hemorrhages and their surgical treatment]. Gosudarstvennoye izdatelstvo meditsinskoi literatury. 2015;196. Russian.
Skvortsov VV, Tumarenko AV. [Clinical Gastroenterology]. Kurs dlya vrachei. 2015;55-57. Russian.
Fomin PD, Nikishev VI. [Bleeding from the upper gastrointestinal tract: causes, risk factors, diagnosis, treatment]. Zdorovye Ukrainy. 2010;5:8-10. Ukrainian.
Iwamoto J, Saito Y, Honda A, Matsuzaki Y. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol. 2013;19(11):1673-82. doi: https://doi.org/10.3748/wjg.v19.i11.1673
Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 2. 1974 Aug;7877:394-7. https://doi.org/10.1016/S0140-6736(74)91770-X
Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, et al. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: The results from the MAGIC study. J Gastroenterol. 2014;49. doi: https://doi.org/10.1007/s00535-013-0868-0.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2019 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.